Atlas Trials

The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection

Clinical trial NCT03253250 · UNKNOWN

Trial details

NCT number
NCT03253250
Sponsor
Huashan Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis bHepatic Carcinoma
Start date
2017-09-01
Primary completion
2019-06-01
Enrollment
432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.